Intrathecal medicines
30 results
Applied filters
Hydrocortisone acetate: informing intrathecal risk assessment
18 April 2026Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Baclofen: informing intrathecal risk assessment
18 April 2026Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Shelf lives of aseptically prepared medicines in NRFit syringes
15 April 2026Provision of intrathecal and epidural injections in NRFit syringes may involve extrapolation of stability data from luer lock systems
Colistimethate sodium: informing intrathecal risk assessment
15 August 2025Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Understanding risks with intrathecal administration
17 June 2025The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.
Managing an intrathecal chemotherapy service
13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.
Choosing an injectable medicine for intrathecal administration
13 June 2025The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk
Iohexol: informing intrathecal risk assessment
20 May 2025Iohexol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Ziconotide: informing intrathecal risk assessment
19 February 2024Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Intrathecal administration
All our advice on using intrathecal medicines safely.